Abbott and Medtronic are typically regarded as competitors, but the two medical device giants have recently decided to join forces.
Last week, the two companies teamed up to collaborate on a continuous glucose monitoring (CGM)…
Continue Reading
What You Should Know:
– Abbott and Medtronic announced a groundbreaking partnership to develop an integrated continuous glucose monitoring (CGM) system designed to seamlessly work with Medtronic’s automated insulin delivery (AID) and smart insulin pen…
Continue Reading
The Tandem Diabetes Care t:slim X2 Insulin Pump, which is compatible with glucose monitoring specialist Dexcom’s G7 and G6 continuous glucose monitoring (CGM) systems, has been cleared for sale by Health Canada, the department…
Continue Reading
What You Should Know:
– Tandem Diabetes Care announced today that its Tandem Mobi insulin pump is fully compatible with Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring (CGM) systems.
– Tandem is now the only…
Continue Reading
What You Should Know:
– Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous…
Continue Reading
By Shania Kennedy
May 14, 2024 – A research team from the University of Virginia (UVA) Center for Diabetes Technology has demonstrated that incorporating AI into an artificial pancreas system for regulating type 1 diabetes improves…
Continue Reading
Eli Lilly and Company has added Amazon Pharmacy as a third-party dispensing provider for LillyDirect Pharmacy Solutions, meaning the company will provide home delivery services for certain medications through LillyDirect, the companies announced Wednesday.
LillyDirect,…
An over-the-counter continuous glucose monitoring (CGM) solution developed by Dexcom called Stelo has received clearance from the Food and Drug Administration (FDA).Available without the need for a prescription, the wearable biosensor boasts a battery…
Continue Reading
What You Should Know:
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose biosensor that doesn’t…
Continue Reading
Kakao Healthcare has unveiled its latest AI-driven mobile diabetes management app. Called PASTA (Personalised, Accessible, Supportive, Tech-enabled, and Affordable), the app currently links to two CGM devices: CareSens Air by local manufacturer i-SENS and Dexcom’s…
Continue Reading
